High-risk prescribing in older people: More harm than good?

Aging Health

Volumn 8, Issue 4, 2012, Pages 325-327

  Gnjidic, Danijela ^a,b   Hilmer, Sarah N ^b,c   Le Couteur, David G ^a,c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

adverse outcomes; benefits and risks; high risk prescribing; medicines; older adults

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; SEDATIVE AGENT;

AGED HOSPITAL PATIENT; AGING; COGNITIVE DEFECT; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; FALLING; FRAIL ELDERLY; GERIATRIC CARE; GERIATRIC DISORDER; HIGH RISK POPULATION; HUMAN; INAPPROPRIATE PRESCRIBING; MORTALITY; OUTCOME ASSESSMENT; PHYSICAL DISEASE; POLYPHARMACY; PRESCRIPTION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

EID: 84868133338     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.12.35     Document Type: Editorial

References (20)

1. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol. Rev. 56, 163-184 (2004). (Pubitemid 38720828)
2. Hilmer SN, Gnjidic D, Abernethy DR. Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults. J. Gerontol. A. Biol. Sci. Med. Sci. 67, 181-188 (2012).
3. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin. Pharmacol. Ther. 85, 86-88 (2009).
4. Gnjidic D, Hilmer SN, Blyth F et al. High risk prescribing and incidence of frailty among older community-dwelling men. Clin. Pharmacol. Ther. 91, 521-528 (2012).
5. Jyrkka J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study. Eur. J. Clin. Pharmacol. 62, 151-158 (2006).
6. Jyrkka J, Enlund H, Lavikainen P, Sulkava R, Hartikainen S. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol. Drug. Saf. 20, 514-522 (2011).
7. Gnjidic D, Hilmer SN, Blyth F et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J. Clin. Epidemiology doi:10.1016/j. jclinepi.2012.02.018 (2012) (Epub ahead of print).
8. Gnjidic D, Hilmer SN. Use of potentially inappropriate medications in the care of frail older people. Aging. Health. 6, 705-716 (2010).
9. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch. Intern. Med. 163, 2716-2724 (2003). (Pubitemid 37517412)
10. Aparasu RR, Mort Jr. Inappropriate prescribing for the elderly: beers criteria-based review. Ann. Pharmacother. 34, 338-346 (2000). (Pubitemid 30133598)
11. Fick D, Semla T, Beizer J et al. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 60, 616-631 (2012).
12. Hilmer SN, Mager DE, Simonsick EM et al. A drug burden index to define the functional burden of medications in older people. Arch. Intern. Med. 167, 781-787 (2007). (Pubitemid 46658335)
13. Gnjidic D, Cumming RG, Le Couteur DG et al. Drug Burden Index and physical function in older Australian men. Br. J. Clin. Pharmacol. 68, 97-105 (2009).
14. Wilson NM, Hilmer SN, March LM et al. Associations between Drug Burden Index and falls in older people in residential aged care. J. Am. Geriatr. Soc. 59, 875-880 (2011).
15. Gnjidic D, Bell JS, Hilmer SN, Lonnroos E, Sulkava R, Hartikainen S. Drug Burden Index associated with function in community-dwelling older people in Finland: a cross-sectional study. Ann. Med. doi:10.3109/078538 90.2011.573499 (2011) (Epub ahead of print).
16. Lowry E, Woodman RJ, Soiza RL, Hilmer SN, Mangoni AA. Drug burden index, physical function, and adverse outcomes in older hospitalized patients. J. Clin. Pharmacol. doi:10.1177/0091270011421489 (2011) (Epub ahead of print).
17. Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J. Am. Geriatr. Soc. 55, 780-791 (2007). (Pubitemid 46668974)
18. Gray SL, LaCroix AZ, Aragaki AK et al. Angiotensin-converting enzyme inhibitor use and incident frailty in women aged 65 and older: prospective findings from the Women's Health Initiative Observational Study. J. Am. Geriatr. Soc. 57, 297-303 (2009).
19. LaCroix AZ, Gray SL, Aragaki A et al. Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational Study. J. Gerontol. A. Biol. Sci. Med. Sci. 63, 369-375 (2008). (Pubitemid 351738418)
20. Le Couteur DG, Banks E, Gnjidic D, McLachlan AJ. Deprescribing. Aust. Prescr. 34, 182-185 (2011).